Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant

被引：0
|
作者：
Vo, A. [1 ]
Choi, J. [1 ]
Kim, I. [1 ]
Huang, E. [1 ]
Louie, S. [1 ]
Kang, A. [1 ]
Williamson, S. [1 ]
Myers, K. [1 ]
Peng, A. [1 ]
Najjar, R. [1 ]
Jordan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Kidney Transplant, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
108
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [1] Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR).
    Choi, J.
    Aubert, O.
    Louie, S.
    Ammerman, N.
    Vo, A.
    Peng, A.
    Huang, E.
    Najjar, R.
    Puliyanda, D.
    Sethi, S.
    Haas, M.
    Lim, K.
    Loupy, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 326 - 327
  • [2] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Antibody-Mediated Rejection (ABMR) in Pediatric Renal Transplant Patients
    Steggerda, Justin
    Puliyanda, Dechu
    Todo, Tsuyoshi
    Haas, Mark
    Zhang, Xioahai
    Choi, Jua
    Pizzo, Helen
    Jordan, Stanley
    Kim, Irene
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 52 - 52
  • [3] Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection
    Shin, Bong-Ha
    Everly, Matthew J.
    Zhang, Hao
    Choi, J.
    Vo, Ashley
    Zhang, Xiaohai
    Huang, Edmund
    Jordan, Stanley C.
    Toyoda, Mieko
    TRANSPLANTATION, 2020, 104 (04) : 856 - 863
  • [4] Tocilizumab (Anti-IL-6 Receptor Antibody) and Intravenous Immunoglobulin (IVIG) in Difficult To Desensitize Patients: Phase I/II Trial
    Vo, Ashley
    Kim, Jua
    Kim, Irene
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 49 - 49
  • [5] CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962)
    Vo, Ashley
    Ammerman, Noriko
    Huang, Edmund
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Najjar, Reiad
    Williamson, Summer
    Myers, Catherine
    Sethi, Supreet
    Lim, Kathlyn
    Choi, Jua
    Jordan, Stanley
    TRANSPLANTATION, 2020, 104 (09) : S104 - S105
  • [6] Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)
    Vo, A. A.
    Ammerman, N.
    Huang, E.
    Toyoda, M.
    Ge, S.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Williamson, S.
    Myers, C.
    Lim, K.
    Gillespie, M.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 372 - 372
  • [7] Practical management of patients on anti-IL6R therapy - the CRI guidelines
    Morel, Jacques
    Tournadre, Anne
    Sellam, Jeremie
    Pham, Thao
    Richez, Christophe
    JOINT BONE SPINE, 2021, 88 (04)
  • [8] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients.
    Puliyanda, D.
    Kim, I.
    Choi, J.
    Haas, M.
    Zhang, X.
    Vo, A.
    Pizzo, H.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 267 - 268
  • [9] Saftey & Long Term Outcomes of Tocilizumab (Anti-IL6R, TCZ) Therapy in Treatment of Chronic Antibody Mediated Rejection (CABMR) & Transplant Glomerulopathy (TG) in Highly-HLA Sensitized (HS) Patients (PTs)
    Choi, J.
    Aubert, O.
    Vo, A.
    Loupy, A.
    Haas, M.
    Louie, S.
    Kang, A.
    Peng, A.
    Najjar, R.
    Huang, E.
    Toyota, M.
    Zhang, X.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 308 - 308
  • [10] Anti-IL6R Therapy (Tocilizumab) Improves Long-Term Patient & Graft Survival in Patients with Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.
    Choi, J.
    Vo, A.
    Haas, M.
    Puliyanda, D.
    Louie, S.
    Peng, A.
    Kahwaji, J.
    Villicana, R.
    Kim, I.
    Mirocha, J.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 350 - 350
12345